Not applicableEnded earlyNCT00147238
What this trial is testing
A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast
Who this might be right for
Bladder CancerGenitourinary CancerProstate Cancer
M.D. Anderson Cancer Center 10